Tittarelli, A.; Pereda, C.; Gleisner, M.A.; López, M.N.; Flores, I.; Tempio, F.; Lladser, A.; Achour, A.; González, F.E.; Durán-Aniotz, C.;
et al. Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy. Vaccines 2024, 12, 357.
https://doi.org/10.3390/vaccines12040357
AMA Style
Tittarelli A, Pereda C, Gleisner MA, López MN, Flores I, Tempio F, Lladser A, Achour A, González FE, Durán-Aniotz C,
et al. Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy. Vaccines. 2024; 12(4):357.
https://doi.org/10.3390/vaccines12040357
Chicago/Turabian Style
Tittarelli, Andrés, Cristian Pereda, MarÃa A. Gleisner, Mercedes N. López, Iván Flores, Fabián Tempio, Alvaro Lladser, Adnane Achour, FermÃn E. González, Claudia Durán-Aniotz,
and et al. 2024. "Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy" Vaccines 12, no. 4: 357.
https://doi.org/10.3390/vaccines12040357
APA Style
Tittarelli, A., Pereda, C., Gleisner, M. A., López, M. N., Flores, I., Tempio, F., Lladser, A., Achour, A., González, F. E., Durán-Aniotz, C., Miranda, J. P., Larrondo, M., & Salazar-Onfray, F.
(2024). Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy. Vaccines, 12(4), 357.
https://doi.org/10.3390/vaccines12040357
